NCT00969111Recruiting
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy
Source: ClinicalTrials.gov · Last updated 17 Jun 2026
Brief summary (registry, in English)
The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returned or the risk of prostate cancer returning.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 28 Aug 2009
- Start date
- 1 Aug 2009
- Primary completion date
- 31 Aug 2031
- Lead sponsor
- Proton Collaborative Group
- Diseases
- Prostate cancer
- NCT number
- NCT00969111
What you commit to
- Study type: Interventional
- Planned participants: 70
- From 1 Aug 2009 to the primary completion date, 31 Aug 2031
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior systemic chemotherapy for any reason.
- Previous irradiation to the pelvis that would compromise the ability to deliver the prescribed study treatment.
- Prior or concurrent cancer, other than non-melanomatous skin cancer, unless disease free for at least 5 years.
- Taking Saw Palmetto or methotrexate and unable or unwilling to discontinue its use during radiation.
Other illness
- Active inflammatory bowel disease (Crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum. (Non-active diverticulitis and Crohn's disease not affecting the rectum are allowed).
Other
- Evidence of distant metastasis (M1).
Who the study is looking for
- Prostate cancer treated primarily with open, laparoscopic or robotically assisted prostatectomy.
- Maximum PSA value of 20 ng/ml.
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Inova Schar Cancer Institute Coordinator of this site? Confirm its status | Fairfax | United States | Recruiting |
| McLaren Proton Therapy Center Coordinator of this site? Confirm its status | Flint | United States | Recruiting |
| University of Florida Proton Therapy Institute Coordinator of this site? Confirm its status | Jacksonville | United States | Recruiting |
| Proton Center of Arkansas Coordinator of this site? Confirm its status | Little Rock | United States | Recruiting |
| Mercy David C. Pratt Cancer Center Coordinator of this site? Confirm its status | St Louis | United States | Recruiting |
| Northwestern Medicine Chicago Proton Center Coordinator of this site? Confirm its status | Warrenville | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.